8:00 AM -9:20 AM Module 1: Pancreas/Liver
Moderators: Toba Weinstein, MD, Cohen Children's Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Lara Hart, MD, Humber Regional Hospital

8:00 AM Acute Pancreatitis Course: Managing the Unexpected!
                        Maisam Abu-El-Haija, MD, MS, Cincinnati Children's Hospital and Medical Center
                        Learning objectives:

• Understand the element for diagnosis and staging of acute pancreatitis in children
• Understand the management components of acute pancreatitis in children
• Determine the long-term outcomes after resolution of the acute pancreatitis course

8:20 AM Pediatric MASLD: Advances in Risk Stratification and Management
                        Samar Ibrahim, MBChB, Mayo Clinic
                        Learning  objectives:

• Understand the evolving pathophysiology of MASLD, including key metabolic drivers and their relevance to risk stratification
• Evaluate the advances in screening and non-invasive diagnostic tools for MASLD, with emphasis on blood-based biomarkers, imaging modalities, and risk prediction models
• Recognize the multidisciplinary management strategy and novel/emerging therapeutic and disease modifying approaches in MASLD

8:40 AM Help: My Patient With Cirrhosis is Decompensating
                        Amy Feldman, MD, Children's Hospital Colorado
                        Learning objectives:

• Recognize when a patient with cirrhosis is experiencing decompensation
• Understand how to manage infection, ascites, and bleeding in a patient with decompensated cirrhosis
• Recognize when a patient with cirrhosis needs to be listed for liver transplantation

9:00 AM SOS: I need a Hepatologist (Top 3 Liver Consults for General GI)
                        Saeed Mohammad, MD, Monroe Carell Jr. Children's Hospital at Vanderbilt
                        Learning objectives:

• Differentiate between common causes of neonatal cholestasis, including prematurity, total parenteral nutrition (TPN)-associated cholestasis, genetic disorders, and biliary atresia
• Recognize clinical and laboratory features of drug-induced liver injury (DILI), and develop an evidence-based approach to management, including when to discontinue the offending agent
• Formulate an appropriate evaluation and management plan for patients presenting with an elevated INR (>3) in the outpatient setting, including strategies for urgent versus elective intervention

9:20 AM -9:40 AM Break

9:40 AM -10:40 AM Module 2: FGID/Motility
Moderators: Maria E. Perez, DO, Lurie Children's Hospital and Northwestern University Feinberg School of Medicine and Terry Sigman, MD, FRCPC, Montreal Children’s Hospital

9:40 AM           Evaluation and Management of Pediatric Refractory Constipation
                        Leonel Rodriguez, MD, MS, Yale University
                        Learning objectives:

• Definition and epidemiology of pediatric refractory constipation
• Discuss the utility of diagnostic studies in the evaluation of pediatric refractory constipation
• Discuss the safety and efficacy of medical therapy in the treatment of pediatric refractory constipation
• Describe and discuss the role of surgery and other interventions in pediatric refractory constipation

10:00 AM         Diagnosis and Management of Cyclic Vomiting Syndrome
                        Katja Karrento, MD, Medical College of Wisconsin
                        Learning objectives:

• Review new diagnostic criteria and testing recommendations for pediatric CVS
• Overview of NASPGHAN 2025 CVS management guidelines

10:20 AM         SOS: Dual Diagnosis - Chronic Luminal Disease with a DGBI Overlap
                        Miguel Saps, MD, University of Miami School of Medicine
                        Learning objectives:

• Recognize the common clinical features of chronic luminal gastrointestinal diseases (e.g., inflammatory bowel disease, celiac disease) and disorders of gut-brain interaction (DGBI)
• Clinical implications of overlapping chronic luminal disease and DGBI in pediatric populations
• Discuss management strategies for children with coexisting chronic luminal disease and DGBI

10:40 AM -11:00 AM Break

11:00 AM -12:00 PM Module 3: Endoscopy
Moderators: Toba Weinstein, MD, Cohen Children's Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Alexander Koral, MD, Yale School of Medicine

11:00 AM Caustic Ingestions: From Acute Endoscopic Management to Chronic Care
                        Michael Manfredi, MD, Children's Hospital of Philadelphia
                        Learning objectives:

• Describe the initial clinical assessment and indications for endoscopy following caustic ingestion, including timing and patient selection for endoscopy
• Identify appropriate endoscopic and medical management strategies for acute caustic injuries, with an emphasis on minimizing complications such as perforation and stricture formation
• Develop a framework for long-term care of pediatric patients following caustic ingestion, including multidisciplinary coordination, surveillance planning, and interventions for chronic esophageal disease

11:20 AM Device-Assisted Enteroscopy: Overview of Techniques, Indications, Risks & Limitations
                        Travis Piester, MD, Seattle Children's Hospital
                        Learning objectives:

• Provide an overview of the types of device-assisted enteroscopy available in pediatrics
• Understand the common indications and uses for device-assisted enteroscopy in pediatrics
• Understand the risks and limitations of device-assisted enteroscopy

11:40 AM SOS: Tubes of the Trade: A Practical Guide to Pediatric Enteral Access
                        Inna Novak, MD, The Children's Hospital at Montefiore
                        Learning objectives:

• Describe the indications, contraindications, and selection criteria for various types of pediatric enteral access
• Review the latest devices and technologies available for pediatric enteral access (including gastrostomy, gastrojejunostomy, and cecostomy tubes)
• Discuss strategies for recognizing, managing, and preventing common peri- and post-procedural complications related to pediatric enteral access

12:00 PM -1:20 PM Lunch on Your Own/Learning Lunches*

*Learning Lunches are separately ticketed events and require advance registration. You need to be registered for the Postgraduate Course in order to register for a Learning Lunch.

1. Evolving Therapies and Management for Acute Pancreatitis
Maisam Abu-El-Haija, MD, Cincinnati Children's Hospital and Medical Center and Nadia Ovchinsky, MD, MBA, FAASLD, NYU Grossman School of Medicine

2. HELP: Handling Liver Emergencies When A Hepatologist is Unavailable
Amy Feldman, MD, Children's Hospital Colorado and Mercedes Martinez, MD, New York Presbyterian Hospital

3. I’m Stuck! My patient still won’t poop!
Leonel Rodriguez, MD, MS, Yale University and Kari F. Baber, PhD, Children's Hospital of Philadelphia

4. Prioritizing Medications in the Challenging IBD Patient
Joel R. Rosh, MD, The Steven and Alexandra Cohen Children's Medical Center of New York and Daphne Say, MD, UC Davis

5. Eosinophilic Esophagitis – Diet, Drugs, Decisions?
Dominique Bailey, MD, Columbia University Irving Medical Center and Shauna Schroeder, MD, Phoenix Children's Hospital

6. Does My Child Have a Food Allergy or Sensitivity?
Victoria Mackenzie Martin, MD, MPH, Massachusetts General Hospital and Sonia Michail, MD, Children's Hospital Los Angeles

7. When Your Patient Refuses to Eat
Praveen S. Goday, MBBS, Nationwide Children's Hospital and Shifra Koyfman, MD, Cohen Children's Medical Center/Northwell Health

8. When Sugars Go Bad-Disaccharides Deficiencies
Tanaz Danialifar, MD, CHLA and Lisa Fahey, MD, Children's Hospital of Philadelphia

1:20 PM -2:40 PM Module 4: Inflammatory Disease
Moderators: Maria E. Perez, DO, Lurie Children's Hospital and Northwestern University Feinberg School of Medicine and Paul Rufo, MD, MMSc, Boston Children's Hospital

1:20 PM Diagnostic Dilemmas and Approach to Patients with EoE
                        Dominique Bailey, MD, Columbia University Irving Medical Center
                        Learning objectives:

• Identify key aspects of the guidelines and how to apply them for diagnosis and management of EoE in clinical practice
• Review how to approach gaps in EoE guidelines using a case-based approach
• Discuss future directions in the diagnosis and management of EoE

1:40 PM Management of Milk Protein Intolerance in the Age of Allergy: Are we doing it all wrong?
                        Victoria Mackenzie Martin, MD, MPH, Massachusetts General Hospital
                        Learning objectives:

• Describe the role of a home milk challenge in the diagnosis of FPIAP/CMPA based on international guidelines, including timing and clinical criteria for implementation
• Evaluate the limitations of guaiac testing for diagnosing FPIAP/CMPA in infants, including the evidence base and validity concerns
• Discuss the association between FPIAP/CMPA and increased risk of IgE-mediated food allergies, and analyze current evidence regarding the timing of introduction of other allergens in infancy

2:00 PM The Era of Disease Modification in IBD
                        David T Rubin, MD, University of Chicago
                        Learning objectives:

• Incorporate the evolving goals of IBD into daily practice
• Understand the concept of disease modification in IBD and how to explain it to patients and parents
• Develop a pragmatic strategy to achieve disease modification in patients with Crohn’s disease and ulcerative colitis

2:20 PM SOS: Treatment De-escalation in IBD: Is Anything Forever?
                        Joel R. Rosh, MD, FACG, AGAF, NASPGHAN-F, The Steven and Alexandra Cohen Children's
                        Medical Center of New York
                        Learning objectives:

• Participants will review the treat to target goals of Pediatric IBD therapy
• Treatments used to induce remission will be explored and differentiated from those used to maintain steroid-free remission
• Strategies to personalize therapy of Pediatric IBD will be explored

2:40 PM -3:00 PM Break